Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tilmanocept vs. Sulfur Colloid for SLNBx in Breast Cancer
NCT03199560Phase 4Unknown
- Sponsor
- Memorial Health University Medical Center
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of technetium tc 99m tilmanocept in breast cancer (2 arms), sponsored by Memorial Health University Medical Center. Primary endpoint: Number of harvested lymph nodes at 1 day. Status: unknown.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03199560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199560.